SÍNDROME POSCOVID-19 Y NUTRICIÓN: UNA PERSPECTIVA DE MANEJO

  • David López Centro Latinoamericano de Nutrición (CELAN)
  • Cristina Posada Centro Latinoamericano de Nutrición (CELAN)
  • Patricia Savino Centro Latinoamericano de Nutrición (CELAN)
Palabras clave: infecciones por coronavirus, estado nutricional, signos y síntomas, suplementos dieteticos

Resumen

Durante los dos primeros años de la pandemia por COVID-19, los esfuerzos para su manejo se han enfocado en la prevención, el manejo de los síntomas y la evaluación de tratamientos para reducir la morbilidad y mortalidad derivada de esta enfermedad. Sin embargo, estudios de largo plazo han identificado que las personas infectadas pueden presentar síntomas de larga duración (mayor o igual a 12 semanas). A esta condición se le ha denominado síndrome poscovid-19. Algunos de los síntomas más frecuentes que se han descrito son: debilidad, malestar general, fatiga, alteración en la concentración y la dificultad para respirar, en conjunto con la presencia de respuesta inflamatoria de bajo grado. Adicionalmente, la pérdida de apetito, la diarrea, la anosmia, la ageusia, las náuseas y vómitos tienen un efecto negativo sobre el estado metabólico y nutricional, así como la capacidad funcional de los individuos con esta condición. Una alimentación alta en proteínas, ácidos grasos omega 3 y de micronutrientes, probióticos y suplementación nutricional pueden contribuir a reducir los síntomas observados y mejorar el estado nutricional. Esta revisión busca describir los efectos sobre el estado metabólico y nutricional en personas con síndrome poscovid-19, así como dar algunas alternativas de manejo nutricional.

Biografía del autor

David López, Centro Latinoamericano de Nutrición (CELAN)
Nutricionista Dietista, Especialista en epidemiología clínica. Centro Latinoamericano de Nutrición (CELAN). Chía (Cundinamarca), Colombia.
Cristina Posada, Centro Latinoamericano de Nutrición (CELAN)
Nutricionista Dietista, Especialista en bioquímica clínica. Centro Latinoamericano de Nutrición (CELAN). Chía (Cundinamarca), Colombia.
Patricia Savino, Centro Latinoamericano de Nutrición (CELAN)
Nutricionista Dietista, MBA en salud. Centro Latinoamericano de Nutrición (CELAN). Chía (Cundinamarca).

Citas

1.COVID-19 Map [Internet]. Johns Hopkins Coronavirus Resource Center. [consultado 24 febrero 2022]. Disponible en: https://coronavirus.jhu.edu/map.html
2. Barber MS, Barrett R, Bradley RD, Walker E. A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review. Complement Ther Med. 2021; 63:102788.
3. Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, et al. A Review of Persistent Post-COVID Syndrome (PPCS). Clin Rev Allergy Immunol [Internet]. 2021 [consultado 24 febrero 2022]; Disponible en: https://link.springer.com/article/10.1007/s12016-021-08848-3
4. Maamar M, Artime A, Pariente E, Fierro P, Ruiz Y, Gutiérrez S, et al. Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study. Curr Med Res Opin. 2022; 1-9.
5. Cereda E, Clavé P, Collins PF, Holdoway A, Wischmeyer PE. Recovery Focused Nutritional Therapy across the Continuum of Care: Learning from COVID-19. Nutrients. 2021; 13(9):3293.
6. Vaillant M-F, Agier L, Martineau C, Philipponneau M, Romand D, Masdoua V, et al. Food intake and weight loss of surviving inpatients in the course of COVID-19 infection: A longitudinal study of the multicenter NutriCoviD30 cohort. Nutrition. 2022; 93:111433.
7. National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN), Royal College of General Practitioners (RCGP). COVID-19 rapid guideline: managing the longterm effects of COVID-19. London, United Kingdom: National Institute for Health and Care Excellence (NICE); Report No.: NICE guideline [NG188].
8. Saavedra CH, Grupo de expertos participantes en el desarrollo del consenso. IX. Síndrome Post COVID-19: complicaciones tardías y rehabilitación. Infectio. 2021; 25 (4 Supl 1):289-344.
9. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021; 27(4):601-15.
10. Jennings G, Monaghan A, Xue F, Mockler D, RomeroOrtuño R. A Systematic Review of Persistent Symptoms and Residual Abnormal Functioning following Acute COVID-19: Ongoing Symptomatic Phase vs. Post-COVID-19 Syndrome. J Clin Med. 2021; 10(24):5913.
11. Knight DRT, Munipalli B, Logvinov II, Halkar MG, Mitri G, Dabrh AMA, et al. Perception, Prevalence, and Prediction of Severe Infection and Post-acute Sequelae of COVID-19. Am J Med Sci. 2022; S0002-9629(22):00002-7.
12. Hossain MA, Hossain KMA, Saunders K, Uddin Z, Walton LM, Raigangar V, et al. Prevalence of Long COVID symptoms in Bangladesh: a prospective Inception Cohort Study of COVID-19 survivors. BMJ Glob Health. 2021; 6(12):e006838.
13. Kayaaslan B, Eser F, Kalem AK, Kaya G, Kaplan B, Kacar D, et al. Post-COVID syndrome: A single-center questionnaire study on 1007 participants recovered from COVID-19. J Med Virol. 2021; 93(12):6566-74.
14. Fernández-de-Las-Peñas C, Pellicer-Valero OJ, Navarro-Pardo E, Palacios-Ceña D, Florencio LL, Guijarro C, et al. Symptoms Experienced at the Acute Phase of SARS-CoV-2 Infection as Risk Factor of Long-term Post-COVID Symptoms: The LONG-COVID-EXP-CM Multicenter Study. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2022; S1201-9712(22):00007-8.
15. Fang X, Ming C, Cen Y, Lin H, Zhan K, Yang S, et al. Post-sequelae one year after hospital discharge among older COVID-19 patients: A multi-center prospective cohort study. J Infect. 2021; S0163-4453(21):00596-X.
16. Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E, et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2021; 27(10):1507-13.
17. Ghosn J, Piroth L, Epaulard O, Le Turnier P, Mentré F, Bachelet D, et al. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2021;27(7):1041. e1-1041.e4.
18. Martin-Loeches I, Motos A, Menéndez R, Gabarrús A, González J, Fernández-Barat L, et al. ICU-Acquired Pneumonia Is Associated with Poor Health Post-COVID-19 Syndrome. J Clin Med. 2021; 11(1):224.
19. Tosato M, Carfì A, Martis I, Pais C, Ciciarello F, Rota E, et al. Prevalence and Predictors of Persistence of COVID-19 Symptoms in Older Adults: A Single-Center Study. J Am Med Dir Assoc. 2021; 22(9):1840-4.
20. Tleyjeh IM, Saddik B, AlSwaidan N, AlAnazi A, Ramakrishnan RK, Alhazmi D, et al. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up. PloS One. 2021; 16(12):e0260568.
21. Fernández-de-Las-Peñas C, Torres-Macho J, ElviraMartínez CM, Molina-Trigueros LJ, Sebastián-Viana T, Hernández-Barrera V. Obesity is associated with a greater number of long-term post-COVID symptoms and poor sleep quality: A multicentre case-control study. Int J Clin Pract. 2021; 75(12):e14917.
22. Liu Q, Mak JWY, Su Q, Yeoh YK, Lui GC-Y, Ng SSS, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022; 71(3):544-552.
23. Cha C, Baek G. Symptoms and management of long COVID: A scoping review. J Clin Nurs. 2021.
24. Pavli A, Theodoridou M, Maltezou HC. Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals. Arch Med Res. 2021; 52(6):575-81.
25. Hayes LD, Ingram J, Sculthorpe NF. More Than 100 Persistent Symptoms of SARS-CoV-2 (Long COVID): A Scoping Review. Front Med. 2021; 8:750378.
26. Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, et al. Multiorgan impairment in lowrisk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021; 11(3):e048391.
27. Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021; 6(9):e005427.
28. Gérard M, Mahmutovic M, Malgras A, Michot N, Scheyer N, Jaussaud R, et al. Long-Term Evolution of Malnutrition and Loss of Muscle Strength after COVID-19: A Major and Neglected Component of Long COVID-19. Nutrients. 2021;13(11):3964.
29. Pinzón-Espitia OL, Pardo-Oviedo JM, Murcia Soriano LF. Nutritional risk and clinical outcomes in patients diagnosed with COVID-19 in a high-complexity hospital network. Nutr Hosp. 2022;39(1):93-100.
30. Tsoukalas D, Sarandi E, Georgaki S. The snapshot of metabolic health in evaluating micronutrient status, the risk of infection and clinical outcome of COVID-19. Clin Nutr ESPEN. 2021; 44:173-87.
31. Holdoway A. Nutritional management of patients during and after COVID-19 illness. Br J Community Nurs. 2020;25(Sup8):S6-10.
32. Mechanick JI, Carbone S, Dickerson RN, Hernandez BJD, Hurt RT, Irving SY, et al. Clinical Nutrition Research and the COVID-19 Pandemic: A Scoping Review of the ASPEN COVID-19 Task Force on Nutrition Research. JPEN J Parenter Enteral Nutr. 2021;45(1):13-31.
33. Quilliot D, Gérard M, Bonsack O, Malgras A, Vaillant M-F, Di Patrizio P, et al. Impact of severe SARS-CoV-2 infection on nutritional status and subjective functional loss in a prospective cohort of COVID-19 survivors. BMJ Open. 2021; 11(7):e048948.
34. Bedock D, Couffignal J, Bel Lassen P, Soares L, Mathian A, Fadlallah JP, et al. Evolution of Nutritional Status after Early Nutritional Management in COVID-19 Hospitalized Patients. Nutrients. 2021; 13(7):2276.
35. Critical Care D- ietitians Specialist Group (CCSG) of the British Dietetic Association. Guidance on management of nutrition and dietetic services during the COVID-19 pandemic [Internet]. British Dietetic Association; 2020 p. 15. Report No.: Version 2.1. Disponible en: https://www.bda.uk.com/resource/critical-care-dietetics-guidance-covid-19.html
36. Latif J, Elizabeth Weekes C, Julian A, Frost G, Murphy J, Abigail Tronco-Hernandez Y, et al. Strategies to ensure continuity of nutritional care in patients with COVID-19 infection on discharge from hospital: A rapid review. Clin Nutr ESPEN. 2022; 47:106-16.
37. Cawood A, Walters E, Smith T, Sipaul R, Stratton R. A review of nutrition support guidelines for individuals with or recovering from COVID-19 in the Community. 2020; 12(11):3230.
38. Piotrowicz K, Gąsowski J, Michel J-P, Veronese N. PostCOVID-19 acute sarcopenia: physiopathology and management. Aging Clin Exp Res. 2021; 33(10):2887-98.
39. Paddon-Jones D, Rasmussen BB. Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr Metab Care. 2009; 12(1):86-90.
40. Wang P-Y, Li Y, Wang Q. Sarcopenia: An underlying treatment target during the COVID-19 pandemic. Nutrition . 2021;84:111104.
41. Moro K, Nagahashi M, Ramanathan R, Takabe K, Wakai T. Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancer. World J Clin Cases. 2016; 4(7):155-64.
42. Weylandt KH, Chiu C-Y, Gomolka B, Waechter SF, Wiedenmann B. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Prostaglandins Other Lipid Mediat. 2012; 97(3-4):73-82.
43. Fenton JI, Hord NG, Ghosh S, Gurzell EA. Immunomodulation by dietary long chain omega-3 fatty acids and the potential for adverse health outcomes. Prostaglandins Leukot Essent Fatty Acids. 2013; 89(6):379-90.
44. Hawryłkowicz V, Lietz-Kijak D, Kaźmierczak-Siedlecka K, Sołek-Pastuszka J, Stachowska L, Folwarski M, et al. Patient Nutrition and Probiotic Therapy in COVID-19: What Do We Know in 2021? Nutrients. 2021; 13(10):3385.
45. Rogero MM, Leão M de C, Santana TM, Pimentel MV de MB, Carlini GCG, da Silveira TFF, et al. Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19. Free Radic Biol Med. 2020; 156:190-9.
46. de Faria Coelho-Ravagnani C, Corgosinho FC, Sanches FLFZ, Prado CMM, Laviano A, Mota JF. Dietary recommendations during the COVID-19 pandemic. Nutr Rev. 2021; 79(4):382-93.
47. Calder PC. Nutrition and immunity: lessons for COVID-19. Nutr Diabetes. 2021; 11(1):19.
48. Tepasse P-R, Vollenberg R, Fobker M, Kabar I, Schmidt H, Meier JA, et al. Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis. Nutrients. 2021; 13(7):2173.
49. Cereda E, Bogliolo L, Klersy C, Lobascio F, Masi S, Crotti S, et al. Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital. Clin Nutr Edinb Scotl. 2021; 40(4):2469-72.
50. Afaghi S, Esmaeili Tarki F, Sadat Rahimi F, Besharat S, Mirhaidari S, Karimi A, et al. Prevalence and Clinical Outcomes of Vitamin D Deficiency in COVID-19 Hospitalized Patients: A Retrospective Single-Center Analysis. Tohoku J Exp Med. 2021; 255(2):127-34.
51. Anastasi E, Ialongo C, Labriola R, Ferraguti G, Lucarelli M, Angeloni A. Vitamin K deficiency and covid-19. Scand J Clin Lab Invest. 2020; 80(7):525-7.
52. Shakeri H, Azimian A, Ghasemzadeh-Moghaddam H, Safdari M, Haresabadi M, Daneshmand T, et al. Evaluation of the relationship between serum levels of zinc, vitamin B12, vitamin D, and clinical outcomes in patients with COVID-19. J Med Virol. 2022; 94(1):141-6.
53. Jothimani D, Kailasam E, Danielraj S, Nallathambi B, Ramachandran H, Sekar P, et al. COVID-19: Poor outcomes in patients with zinc deficiency. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2020; 100:343-9. 54. Talha KA, Patwary MI, Alam ZN, Ali SM, Ahmed S, Nafee A, et al. Case-Control Study to Evaluate Zinc Deficiency as a Risk Factor for Oxygen Requirement in Patients with COVID-19. Mymensingh Med J MMJ. 2022; 31(1):216-22.
55. Kilercik M, Ucal Y, Serdar M, Serteser M, Ozpinar A, Schweigert FJ. Zinc protoporphyrin levels in COVID-19 are indicative of iron deficiency and potential predictor of disease severity. PloS One. 2022; 17(2):e0262487.
56. Fakhrolmobasheri M, Mazaheri-Tehrani S, Kieliszek M, Zeinalian M, Abbasi M, Karimi F, et al. COVID-19 and Selenium Deficiency: a Systematic Review. Biol Trace Elem Res. 2021.
57. Beigmohammadi MT, Bitarafan S, Abdollahi A, Amoozadeh L, Salahshour F, Mahmoodi Ali Abadi M, et al. The association between serum levels of micronutrients and the severity of disease in patients with COVID-19. Nutr Burbank Los Angel Cty Calif. 2021; 91-92:111400.
58. Hackler J, Heller RA, Sun Q, Schwarzer M, Diegmann J, Bachmann M, et al. Relation of Serum Copper Status to Survival in COVID-19. Nutrients. 2021; 13(6):1898.
59. Fedele D, De Francesco A, Riso S, Collo A. Obesity, malnutrition, and trace element deficiency in the coronavirus disease (COVID-19) pandemic: An overview. Nutr Burbank Los Angel Cty Calif. 2021; 81:111016.
60. Gorji A, Khaleghi Ghadiri M. Potential roles of micronutrient deficiency and immune system dysfunction in the coronavirus disease 2019 (COVID-19) pandemic. Nutr Burbank Los Angel Cty Calif. 2021; 82:111047.
61. Muthuvattur Pallath M, Ahirwar AK, Chandra Tripathi S, Asia P, Sakarde A, Gopal N. COVID-19 and nutritional deficiency: a review of existing knowledge. Horm Mol Biol Clin Investig. 2021; 42(1):77-85.
62. Tan CW, Ho LP, Kalimuddin S, Cherng BPZ, Teh YE, Thien SY, et al. Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19). Nutr Burbank Los Angel Cty Calif. 2020; 79-80:111017.
63. Majidi N, Rabbani F, Gholami S, Gholamalizadeh M, BourBour F, Rastgoo S, et al. The Effect of Vitamin C on Pathological Parameters and Survival Duration of Critically Ill Coronavirus Disease 2019 Patients: A Randomized Clinical Trial. Front Immunol. 2021; 12:717816.
64. Loucera C, Peña-Chilet M, Esteban-Medina M, Muñoyerro-Muñiz D, Villegas R, Lopez-Miranda J, et al. Real world evidence of calcifediol or vitamin D prescription and mortality rate of COVID-19 in a retrospective cohort of hospitalized Andalusian patients. Sci Rep. 2021; 11(1):23380.
65. Beigmohammadi MT, Bitarafan S, Hoseindokht A, Abdollahi A, Amoozadeh L, Soltani D. The effect of supplementation with vitamins A, B, C, D, and E on disease severity and inflammatory responses in patients with COVID-19: a randomized clinical trial. Trials. 2021; 22(1):802.
66. Vitamin and Mineral Nutrition Information System (VMNIS) [Internet]. [citado 10 de febrero de 2022]. Disponible en:
https://www.who.int/teams/nutrition-and-food-safety/databases/vitamin-and-mineral-nutrition-information-system
67. Hummell AC, Cummings M. Role of the nutrition-focused physical examination in identifying malnutrition and its effectiveness. Nutr Clin Pract Off Publ Am Soc Parenter Enter Nutr. 2022; 37(1):41-9.
68. El Zakhem A, Chalhoub MA, Bassil M. The Role of Herbal and Nutritional Treatments in the Fight against COVID-19 and Other Respiratory Tract Infections. Int J Environ Res Public Health. 2021; 18(22):12001.
69. Wu Y, Cheng X, Jiang G, Tang H, Ming S, Tang L, et al. Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization. NPJ Biofilms Microbiomes. 2021; 7(1):61.
70. Xavier-Santos D, Padilha M, Fabiano GA, Vinderola G, Gomes Cruz A, Sivieri K, et al. Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review. Trends Food Sci Technol. febrero de 2022; 120:174-92.
71. Ivashkin V, Fomin V, Moiseev S, Brovko M, Maslennikov R, Ulyanin A, et al. Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum subsp. longum PDV 2301 in the Treatment of Hospitalized Patients with COVID-19: a Randomized Controlled Trial. Probiotics Antimicrob Proteins. 2021;
72. Gutiérrez-Castrellón P, Gandara-Martí T, Abreu Y Abreu AT, Nieto-Rufino CD, López-Orduña E, Jiménez-Escobar I, et al. Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial. Gut Microbes. 2022; 14(1):2018899.
73. de Oliveira GLV, Oliveira CNS, Pinzan CF, de Salis LVV, Cardoso CR de B. Microbiota Modulation of the Gut-Lung Axis in COVID-19. Front Immunol. 2021; 12:635471.
74. Santinelli L, Laghi L, Innocenti GP, Pinacchio C, Vassalini P, Celani L, et al. Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients. Front Nutr. 2021; 8:756177.
75. Rathi A, Jadhav SB, Shah N. A Randomized Controlled Trial of the Efficacy of Systemic Enzymes and Probiotics in the Resolution of Post-COVID Fatigue. Med Basel Switz. 2021; 8(9):47.
76. Jensen G, Cederholm T, Correira I, Gonzalez M, Fukushima R, Higashiguchi T, et al. GLIM Criteria for the diagnosis of malnutrition: A consensus report from the global clinical nutrition community. JPEN J Parenter Enteral Nutr. 2019; 43(1):32-40.
77. Barazzoni R, Bischoff SC, Breda J, Wickramasinghe K, Krznaric Z, Nitzan D, et al. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin Nutr Edinb Scotl. 2020;39(6):1631-8.
Publicado
2022-04-28
Sección
Artículos de Revisión